(MDVL) – Press Releases
-
MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters
-
MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q
-
MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters
-
MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference
-
MedAvail Reports Second Quarter 2023 Financial Results
-
MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters
-
MedAvail Announces 1-for-50 Reverse Stock Split
-
MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources
-
MedAvail Reports First Quarter 2023 Financial Results
-
MedAvail to Report First Quarter 2023 Financial Results on May 18
-
MedAvail Postpones Reporting of First Quarter 2023 Financial Results
-
MedAvail to Report First Quarter 2023 Financial Results on May 15
-
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
-
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13
-
MedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial Results
-
MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on March 30
-
MedAvail Announces Closing of $16 Million Private Placement
-
MedAvail announces Sale of Pharmacy Assets to CVS Pharmacy
-
MedAvail announces Strategic Restructuring of Business to Focus on Profitability
-
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
-
MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America
-
MedAvail Reports Third Quarter 2022 Financial Results
-
MedAvail To Report 2022 Third Quarter Financial Results on November 10, 2022
-
MedAvail Announces Technology Partnership with Progressive Care, Inc
-
MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference
-
MedAvail to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
-
MedAvail Reports Second Quarter 2022 Financial Results
-
MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022
-
MedAvail to Participate in Upcoming Investor Conferences
-
MedAvail Reports First Quarter 2022 Financial Results
-
MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022
-
MedAvail Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
-
MedAvail Announces Closing of Private Placement
-
MedAvail Announces Pricing of $50 Million Private Placement
-
MedAvail Reports Fourth Quarter and Full Year 2021 Financial Results
-
MedAvail to Report 2021 Fourth Quarter and Full Year Financial Results on March 24, 2022
-
MedAvail Strengthens Leadership Team
-
MedAvail Announces Changes to Executive Management and Board of Directors; Preliminary Fourth Quarter and FY 2021 Results
-
IMA Medical Group Significantly Expands Partnership With MedAvail, Providing Integrated SpotRx Pharmacy Experience
-
MedAvail to Present at the Lytham Partners Winter 2021 Investor Conference
-
MedAvail Signs Four SpotRx Locations With Cano Health in California
-
MedAvail Reports Third Quarter 2021 Financial Results
-
InnovaCare Signs Agreement with MedAvail to Open Three SpotRx Locations in Florida
-
MedAvail to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference
-
MedAvail to Report 2021 Third Quarter Financial Results on November 8, 2021
-
MedAvail Appoints Ramona Seabaugh as Chief Financial Officer
-
IMA Medical Group Signs Agreement with MedAvail to Open Four SpotRx Locations in Florida
-
MedAvail to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
-
MedAvail Reports Second Quarter 2021 Financial Results
-
SpotRx Joins Zipdrug’s Pharmacy Network
Back to MDVL Stock Lookup
